A/Professor Amanda Vincent
Oestrogen-containing menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms. However, “one size does not fit all” and MHT needs to be individualised to the particular women considering her medical history, co-morbidities, side-effects and preferences. In addition, there are circumstances when MHT is contraindicated and non-hormonal therapies need to be considered. This presentation will present real-life case histories including where MHT was contraindicated or a modification of MHT delivery, dose, or formulation was required, and will discuss the evidence base for efficacy and safety in each case.
The learning outcomes of this presentation are:
- Tailor treatment of menopause symptoms to each individual patient profile
- Identify women with premature ovarian insufficiency (POI) and develop a patient management plan for POI
MBBS (Hon), B. Med Sci (Hon), FRACP, PhD
Clinical Associate Professor Amanda Vincent is a clinician researcher combining clinical practice in menopause with menopause related research, translation and education. She is consultant endocrinologist in the Menopause clinic, Monash Health and Head of Early Menopause Research, Monash Centre for Health Research and Implementation, Monash University with publications and successful grant funding in projects related to early menopause research, consumer and health professional education. She is Past President of the Australasian Menopause Society and a member of the editorial board of the international journal “Climacteric.